ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹5,220 Cr | ₹4,417 Cr | ₹3,340 Cr | ₹3,127 Cr | ₹3,663 Cr |
What is the latest Sundry Debtors ratio of ZYDUS LIFESCIENCES ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹5,220 Cr |
Mar2023 | ₹4,417 Cr |
Mar2022 | ₹3,340 Cr |
Mar2021 | ₹3,127 Cr |
Mar2020 | ₹3,663 Cr |
How is Sundry Debtors of ZYDUS LIFESCIENCES Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹5,220 Cr | 18.19 | |
Mar2023 | ₹4,417 Cr | 32.23 | |
Mar2022 | ₹3,340 Cr | 6.81 | |
Mar2021 | ₹3,127 Cr | -14.63 | |
Mar2020 | ₹3,663 Cr | - |
Compare Sundry Debtors of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹106,088.7 Cr | -5.7% | -12.6% | 68.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,025.0 Cr | -0.4% | 4.7% | 60.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,299.0 Cr | -1.1% | 11% | 43.2% | Stock Analytics | |
CIPLA | ₹132,316.0 Cr | -1.3% | 2.8% | 33.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,579.0 Cr | -2.3% | -7.8% | 14.4% | Stock Analytics | |
MANKIND PHARMA | ₹97,396.6 Cr | -2.7% | 6.6% | 33.4% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -5.7% |
-12.6% |
68.7% |
SENSEX | 0.3% |
3% |
23.3% |
You may also like the below Video Courses